Public preview. Funding rounds, founders, and growth signals require a free account.

Circle Pharma, Inc.

Circle Pharma develops macrocycle-based cancer therapeutics using its proprietary MXMO™ platform to target disease pathways that conventional medications cannot reach. The company aims to create selective cancer treatments with the potential for improved patient tolerability and fewer side effects.

GrowthOtherSan Francisco, CA51-200 employees

Total raised

$330.6M

Last round

Equity

$92.4M · Jun 2024

Stage

Growth

Status

Active

Founders & team

Co-founder, CEO

Co-founder, CTO

Head of Engineering

Head of Sales

🔒

Sign up to see founders

Free account unlocks founder names, LinkedIn profiles, and prior companies.

Create free account

Growth signals

Web traffic

Search interest

Social followers

Glassdoor rating

News mentions

Gov contracts

🔒

Sign up to see signals

Free account unlocks 5 full profiles per day. Pro removes the limit.

Create free account

Track Circle Pharma, Inc. on FlareSight

Get notified the moment Circle Pharma, Inc. files a new round, hires execs, or shows traction signals.

Create free account

About this data

FlareSight surfaces funding data from SEC Form D filings within hours of submission. Browse our full startup funding database to find more recently funded companies.